Option Care Health (NASDAQ:OPCH) Posts Earnings Results

Option Care Health (NASDAQ:OPCH) released its quarterly earnings results on Wednesday. The company reported $0.45 EPS for the quarter, beating the consensus estimate of $0.43 by $0.02, FiscalAI reports. Option Care Health had a net margin of 3.64% and a return on equity of 18.17%. The firm had revenue of $1.44 billion during the quarter, compared to analyst estimates of $1.42 billion. During the same quarter in the prior year, the firm earned $0.41 EPS. The business’s revenue for the quarter was up 1.9% compared to the same quarter last year. Option Care Health updated its FY 2026 guidance to 1.850-1.920 EPS.

Here are the key takeaways from Option Care Health’s conference call:

• Second-quarter results exceeded expectations: Revenue rose 2% year over year to $1.4 billion, adjusted EBITDA increased 3% to $117.5 million, adjusted EPS grew to $0.45, and operating cash flow reached $184 million.
• The acute therapy portfolio delivered another quarter of high-single-digit organic growth, while IG Neuro and rare-and-orphan therapies also posted sequential and year-over-year growth. The company added five ambulatory infusion facilities, with clinic visits up more than 20% year over year.
• Management reported stabilization and sequential patient-census growth in its chronic inflammatory disease portfolio after the first-quarter reset, and expects further improvement through the remainder of 2026. Commercial-team realignment, technology deployment, and AI-enabled workflow improvements are intended to support additional revenue and productivity gains into 2027.
• Option Care repurchased $150 million of stock during the quarter—nearly 5% of shares outstanding—while ending the period with a 2.1x net debt-to-leverage ratio and $525 million remaining under its authorization.
• Full-year revenue guidance was maintained at $5.675 billion–$5.775 billion, while adjusted EBITDA guidance narrowed to $480 million–$495 million and adjusted EPS to $1.85–$1.92. Management continues to expect approximately 600 basis points of revenue pressure and a $55 million gross-profit headwind from the chronic inflammatory disease portfolio in 2026.

Option Care Health Price Performance

Option Care Health stock traded up $1.55 during midday trading on Wednesday, reaching $24.03. 1,947,740 shares of the stock traded hands, compared to its average volume of 2,520,056. The stock’s fifty day moving average is $21.39 and its 200-day moving average is $26.94. Option Care Health has a 12 month low of $18.01 and a 12 month high of $36.80. The stock has a market cap of $3.77 billion, a P/E ratio of 18.62, a PEG ratio of 1.21 and a beta of 0.65. The company has a quick ratio of 1.07, a current ratio of 1.64 and a debt-to-equity ratio of 0.85.

Analyst Ratings Changes

OPCH has been the subject of a number of research reports. TD Cowen reduced their target price on shares of Option Care Health from $37.00 to $23.00 and set a “hold” rating for the company in a report on Friday, May 1st. The Goldman Sachs Group initiated coverage on shares of Option Care Health in a research report on Monday, June 8th. They set a “neutral” rating and a $22.00 price objective for the company. Weiss Ratings cut Option Care Health from a “hold (c-)” rating to a “sell (d+)” rating in a report on Thursday, July 23rd. Barrington Research lowered their target price on Option Care Health from $42.00 to $32.00 and set an “outperform” rating on the stock in a research report on Friday, May 1st. Finally, Truist Financial set a $30.00 price target on Option Care Health in a report on Friday, May 1st. Eight analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Option Care Health has an average rating of “Moderate Buy” and an average target price of $30.08.

Insider Activity at Option Care Health

In other Option Care Health news, CEO John Charles Rademacher acquired 12,500 shares of the company’s stock in a transaction on Monday, May 4th. The stock was acquired at an average cost of $21.18 per share, with a total value of $264,750.00. Following the purchase, the chief executive officer directly owned 695,152 shares of the company’s stock, valued at approximately $14,723,319.36. This represents a 1.83% increase in their position. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Harry M. Jansen Kraemer, Jr. purchased 36,610 shares of the company’s stock in a transaction that occurred on Monday, May 4th. The stock was bought at an average price of $21.41 per share, with a total value of $783,820.10. Following the transaction, the director owned 450,000 shares of the company’s stock, valued at $9,634,500. This represents a 8.86% increase in their position. The SEC filing for this purchase provides additional information. Over the last ninety days, insiders acquired 73,264 shares of company stock valued at $1,548,316. 1.70% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Option Care Health

A number of large investors have recently bought and sold shares of OPCH. Advisory Services Network LLC bought a new position in Option Care Health in the 3rd quarter valued at $35,000. McIlrath & Eck LLC purchased a new stake in shares of Option Care Health during the second quarter valued at $37,000. Caitong International Asset Management Co. Ltd bought a new position in shares of Option Care Health in the third quarter worth about $38,000. Quarry LP grew its holdings in shares of Option Care Health by 502.7% in the third quarter. Quarry LP now owns 1,549 shares of the company’s stock worth $43,000 after purchasing an additional 1,292 shares during the last quarter. Finally, EverSource Wealth Advisors LLC increased its stake in Option Care Health by 528.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,407 shares of the company’s stock worth $46,000 after buying an additional 1,183 shares during the period. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.